CD40 ligand (Celldex Therapeutics)

N/A

Report date: 2023/04/25 14:17:12

Base Information

Drug NameCD40 ligand (Celldex Therapeutics)
Drug Alias NameCD40-LAvrendrHuCD40 ligandrHuCD40Lrecombinant human CD40 ligand (rhuCD40L)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonistsB cells stimulantsDendritic cells stimulants
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsHead and Neck NeoplasmsCarcinoma, Renal CellLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelldex TherapeuticsAmgen Inc
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsCarcinoma, Renal CellLymphoma, Non-Hodgkin +[4] 

Other Information

ATC CodeN/A
Related LinksN/A